The targeted therapy Avastin, alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, progression-free survival times and survival rates in patients with a deadly form of brain cancer that had recurred.
Apparently the drug alone, or in combination with chemotherapy, significantly extended the median survival rage for patients with glioblastoma, a rare but deadly form of brain cancer. Go to cancernews.com to read the article which summarizes recent studies.
Feel good, keep smiling and don’t give up! Cancer patients, there is hope!
Pat & Pattie

Leave a Reply